Viking Global Investors

Holding/activity history for  Amylyx Pharmaceuticals Inc (AMLX)

PeriodShares% of PortfolioActivity% Change to PortfolioReported Price
2023   Q4 2,962,555 0.16 $14.72
2023   Q3 2,962,555 0.22 $18.31
2023   Q2 2,962,555 0.26 $21.57
2023   Q1 2,962,555 0.41 Reduce 36.08% 0.23 $29.34
2022   Q4 4,634,606 0.86 Reduce 19.68% 0.21 $36.95
2022   Q3 5,770,536 0.75 Reduce 19.52% 0.18 $28.15
2022   Q2 7,170,536 0.63 $19.26
2022   Q1 7,170,536 0.37 Buy 0.37 $12.85